{
    "id": "NCLEX_NGN_TREND_500721771",
    "itemType": "trend",
    "caseId": "STROKE_TPA_SAFETY_500",
    "seedId": "MISSION-500-72-1771347494184",
    "topic": "Pharmacological & Parenteral Therapies",
    "subtopic": "Thrombolytics",
    "nclexClientNeed": "Physiological Integrity",
    "nclexSubClientNeed": "Pharmacological and Parenteral Therapies",
    "cognitiveSkill": "Analyzing Cues; Generating Solutions; Taking Action",
    "bloom": "Analyzing",
    "difficulty": 4,
    "status": "active",
    "itemStem": "The nurse in the emergency department is caring for a 68-year-old client diagnosed with an acute ischemic stroke. The stroke team has evaluated the client and an order for alteplase has been entered. Review the client's record. \n\n**Select the 4 findings that require immediate follow-up.**\n\n**Which potential complication is the client at highest risk for developing?**\n\n**For each nursing action, specify if it is Indicated or Contraindicated to perform at this time.**",
    "tabs": [
        {
            "id": "tab1",
            "label": "Nurses' Notes",
            "content": "**13:00:** Client, a 68-year-old Spanish-speaking male, arrives via EMS from a local farm where he works. Onset of symptoms (right-sided facial droop, right arm plegia, expressive aphasia) was 2.5 hours ago per a coworker. Client has a history of hypertension with poor medication adherence. A hospital-approved translation device is being used for communication, which is limited due to aphasia. NIH Stroke Scale (NIHSS) score is 15. Non-contrast head CT and labs sent. Stroke team activated. \n\n**14:15:** Non-contrast head CT results reviewed, showing no hemorrhage. Labetalol 10 mg IV administered for blood pressure management. Client's BP is now within the parameters for alteplase administration. Stroke team has placed the order for alteplase. Awaiting pharmacy delivery."
        },
        {
            "id": "tab2",
            "label": "Vital Signs",
            "content": [
                {
                    "Time": "13:00 (Admission)",
                    "BP": "194/112",
                    "HR": "92",
                    "RR": "18",
                    "SpO2": "97% on RA",
                    "Temp": "37.1°C (98.8°F)"
                },
                {
                    "Time": "13:45 (Post-Labetalol)",
                    "BP": "178/104",
                    "HR": "86",
                    "RR": "16",
                    "SpO2": "98% on RA",
                    "Temp": "N/A"
                },
                {
                    "Time": "14:20 (Current)",
                    "BP": "172/98",
                    "HR": "84",
                    "RR": "16",
                    "SpO2": "98% on RA",
                    "Temp": "N/A"
                }
            ]
        },
        {
            "id": "tab3",
            "label": "Laboratory Results",
            "content": [
                {
                    "Test": "WBC",
                    "Result": "8.9 x 10³/µL",
                    "Reference Range": "4.5-11.0"
                },
                {
                    "Test": "Hemoglobin",
                    "Result": "14.5 g/dL",
                    "Reference Range": "13.5-17.5"
                },
                {
                    "Test": "Hematocrit",
                    "Result": "43%",
                    "Reference Range": "41-53%"
                },
                {
                    "Test": "Platelets",
                    "Result": "82,000/mm³",
                    "Reference Range": "150,000-450,000"
                },
                {
                    "Test": "INR",
                    "Result": "1.0",
                    "Reference Range": "0.8-1.2"
                },
                {
                    "Test": "aPTT",
                    "Result": "31 seconds",
                    "Reference Range": "25-35"
                },
                {
                    "Test": "Glucose, Random",
                    "Result": "155 mg/dL",
                    "Reference Range": "<200"
                },
                {
                    "Test": "Creatinine",
                    "Result": "1.1 mg/dL",
                    "Reference Range": "0.6-1.2"
                },
                {
                    "Test": "Troponin T",
                    "Result": "<0.01 ng/mL",
                    "Reference Range": "<0.04"
                }
            ]
        },
        {
            "id": "tab4",
            "label": "Diagnostic Findings",
            "content": "**Non-Contrast Head CT Report:**\n\n**Impression:** No evidence of acute intracranial hemorrhage, mass, or hydrocephalus. Subtle loss of grey-white differentiation in the left middle cerebral artery (MCA) territory suggestive of early ischemic changes. No contraindications to thrombolytic therapy from a radiographic standpoint."
        },
        {
            "id": "tab5",
            "label": "MAR",
            "content": [
                {
                    "Medication": "Normal Saline 0.9%",
                    "Dose": "75 mL/hr",
                    "Route": "IV",
                    "Status": "Infusing"
                },
                {
                    "Medication": "Labetalol",
                    "Dose": "10 mg",
                    "Route": "IV PUSH",
                    "Status": "Administered at 13:40"
                },
                {
                    "Medication": "Alteplase (tPA)",
                    "Dose": "Per stroke protocol",
                    "Route": "IV Infusion",
                    "Status": "Pending Administration"
                }
            ]
        }
    ],
    "scoringModel": [
        {
            "partId": "part1",
            "type": "multiPoint",
            "scoring": {
                "type": "dichotomous",
                "points": 1,
                "match": {
                    "min": 4,
                    "exact": true
                }
            },
            "layout": {
                "stem": "Select the 4 findings that require immediate follow-up.",
                "options": [
                    {
                        "id": "p1_opt_1",
                        "label": "Platelet count of 82,000/mm³"
                    },
                    {
                        "id": "p1_opt_2",
                        "label": "Expressive aphasia"
                    },
                    {
                        "id": "p1_opt_3",
                        "label": "Blood pressure of 172/98 mmHg"
                    },
                    {
                        "id": "p1_opt_4",
                        "label": "Onset of symptoms 2.5 hours ago"
                    },
                    {
                        "id": "p1_opt_5",
                        "label": "Non-contrast head CT result"
                    },
                    {
                        "id": "p1_opt_6",
                        "label": "Alteplase order pending"
                    },
                    {
                        "id": "p1_opt_7",
                        "label": "Client is Spanish-speaking"
                    }
                ]
            },
            "correctAnswer": {
                "value": [
                    "p1_opt_1",
                    "p1_opt_3",
                    "p1_opt_5",
                    "p1_opt_6"
                ]
            }
        },
        {
            "partId": "part2",
            "type": "cloze",
            "scoring": {
                "type": "dichotomous",
                "points": 1,
                "match": {
                    "exact": true
                }
            },
            "layout": {
                "stem": "Which potential complication is the client at highest risk for developing?",
                "cloze": [
                    {
                        "type": "text",
                        "value": "Which potential complication is the client at highest risk for developing? "
                    },
                    {
                        "type": "dropdown",
                        "id": "p2_cloze_1",
                        "options": [
                            "Hemorrhagic transformation of stroke",
                            "Aspiration pneumonia",
                            "Hypertensive crisis",
                            "Anaphylactic reaction to alteplase"
                        ]
                    }
                ]
            },
            "correctAnswer": {
                "value": {
                    "p2_cloze_1": "Hemorrhagic transformation of stroke"
                }
            }
        },
        {
            "partId": "part3",
            "type": "matrix",
            "scoring": {
                "type": "dichotomous",
                "points": 1,
                "match": {
                    "exact": true
                }
            },
            "layout": {
                "stem": "For each nursing action, specify if it is Indicated or Contraindicated to perform at this time.",
                "rows": [
                    {
                        "id": "p3_row_1",
                        "label": "Administer the alteplase infusion as ordered."
                    },
                    {
                        "id": "p3_row_2",
                        "label": "Notify the healthcare provider of the platelet count."
                    },
                    {
                        "id": "p3_row_3",
                        "label": "Prepare the client for a thrombectomy procedure."
                    },
                    {
                        "id": "p3_row_4",
                        "label": "Place the client on strict NPO status."
                    }
                ],
                "columns": [
                    {
                        "id": "p3_col_1",
                        "label": "Indicated"
                    },
                    {
                        "id": "p3_col_2",
                        "label": "Contraindicated"
                    }
                ]
            },
            "correctAnswer": {
                "value": [
                    {
                        "rowId": "p3_row_1",
                        "columnId": "p3_col_2"
                    },
                    {
                        "rowId": "p3_row_2",
                        "columnId": "p3_col_1"
                    },
                    {
                        "rowId": "p3_row_3",
                        "columnId": "p3_col_2"
                    },
                    {
                        "rowId": "p3_row_4",
                        "columnId": "p3_col_1"
                    }
                ]
            }
        }
    ],
    "answerBreakdown": {
        "part1": [
            {
                "optionId": "p1_opt_1",
                "rationale": "Correct. A platelet count less than 100,000/mm³ is an absolute contraindication for alteplase administration due to the high risk of severe bleeding. This finding is critical and must be addressed immediately.",
                "correct": true
            },
            {
                "optionId": "p1_opt_2",
                "rationale": "Incorrect. Expressive aphasia is an expected clinical manifestation of a stroke affecting the dominant hemisphere (typically left MCA territory) and is part of the reason for treatment, not a contraindication.",
                "correct": false
            },
            {
                "optionId": "p1_opt_3",
                "rationale": "Correct. The current blood pressure of 172/98 mmHg is significant because it is below the 185/110 mmHg threshold required for alteplase administration. This indicates that the previous intervention (labetalol) was effective and BP is currently managed.",
                "correct": true
            },
            {
                "optionId": "p1_opt_4",
                "rationale": "Incorrect. The onset of symptoms 2.5 hours ago is a crucial piece of information that confirms the client is within the standard 3 to 4.5-hour window for alteplase eligibility. While significant, it is an inclusion criterion, not a finding requiring immediate follow-up in the sense of a problem.",
                "correct": false
            },
            {
                "optionId": "p1_opt_5",
                "rationale": "Correct. The non-contrast head CT result is a critical finding because it definitively rules out an acute intracranial hemorrhage, which is the primary requirement before administering a thrombolytic agent.",
                "correct": true
            },
            {
                "optionId": "p1_opt_6",
                "rationale": "Correct. The pending order for alteplase is a significant cue as it represents a planned, high-risk intervention. The nurse must perform a final safety check of all clinical data before proceeding with this order.",
                "correct": true
            },
            {
                "optionId": "p1_opt_7",
                "rationale": "Incorrect. The client being Spanish-speaking is a health equity consideration that affects communication but is not a clinical finding that directly impacts the decision to administer alteplase.",
                "correct": false
            }
        ],
        "part2": [
            {
                "option": "Hemorrhagic transformation of stroke",
                "rationale": "Correct. The client's platelet count is 82,000/mm³, which is significantly below the safety threshold of 100,000/mm³. Administering alteplase, a potent thrombolytic, to a client with thrombocytopenia would dramatically increase the risk of bleeding, including catastrophic intracerebral hemorrhage (hemorrhagic transformation).",
                "correct": true
            },
            {
                "option": "Aspiration pneumonia",
                "rationale": "Incorrect. While clients with stroke are at risk for aspiration due to potential dysphagia, the most immediate, life-threatening complication related to the pending intervention (alteplase) and the critical lab value (low platelets) is hemorrhage.",
                "correct": false
            },
            {
                "option": "Hypertensive crisis",
                "rationale": "Incorrect. The client's blood pressure was successfully lowered with labetalol and is currently within the acceptable range (172/98 mmHg) for alteplase administration. A hypertensive crisis is not the primary risk at this moment.",
                "correct": false
            },
            {
                "option": "Anaphylactic reaction to alteplase",
                "rationale": "Incorrect. Anaphylaxis is a possible but rare adverse effect of alteplase. The most significant and probable risk, based on the client's specific laboratory data (thrombocytopenia), is severe bleeding.",
                "correct": false
            }
        ],
        "part3": [
            {
                "rowId": "p3_row_1",
                "rationale": "Contraindicated. The platelet count of 82,000/mm³ is an absolute contraindication. Proceeding with administration would be a serious medication error and place the client at extreme risk for life-threatening hemorrhage. This is a critical 'SAFETY STOP' moment.",
                "correctColumnId": "p3_col_2"
            },
            {
                "rowId": "p3_row_2",
                "rationale": "Indicated. The nurse has an immediate responsibility to withhold the medication AND notify the prescribing provider of the contraindication. This allows the provider to cancel the order and re-evaluate the plan of care.",
                "correctColumnId": "p3_col_1"
            },
            {
                "rowId": "p3_row_3",
                "rationale": "Contraindicated. While thrombectomy is a treatment for ischemic stroke, it is not an action the nurse would independently prepare for at this moment. The decision to pursue thrombectomy is made by the stroke team based on specific imaging criteria (e.g., large vessel occlusion), which is not indicated in the provided data. The immediate priority is addressing the tPA contraindication.",
                "correctColumnId": "p3_col_2"
            },
            {
                "rowId": "p3_row_4",
                "rationale": "Indicated. All clients with acute stroke should be placed on NPO status until a swallow screen can be performed to assess for dysphagia and prevent aspiration. This is a standard safety precaution in stroke care.",
                "correctColumnId": "p3_col_1"
            }
        ]
    }
}